Page last updated: 2024-08-24

plerixafor and Spinal Cord Injuries

plerixafor has been researched along with Spinal Cord Injuries in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Brennan, FH; Burke, MH; Carpenter, RS; Dorrance, AM; Hall, JCE; Jiang, RR; Karunasiri, M; Marbourg, JM; Mifflin, KA; Mo, XM; Popovich, PG1
Chen, J; Guo, W; Han, H; Li, J; Mao, D; Tang, B; Xiong, M; Yu, H; Zeng, Y1
Chen, XY; Du, LX; Liu, JM; Liu, ZL; Long, XH; Zhao, K; Zhou, Y1
Fandel, TM; Lee, JU; Lee, SM; Lohela, M; Noble-Haeusslein, LJ; Trivedi, A; Werb, Z; Zhang, H1
Cao, Q; Dheen, ST; Ding, P; Ling, EA; Lu, J; Moochhala, S1

Other Studies

5 other study(ies) available for plerixafor and Spinal Cord Injuries

ArticleYear
Spinal cord injury causes chronic bone marrow failure.
    Nature communications, 2020, 07-24, Volume: 11, Issue:1

    Topics: Animals; Benzylamines; Bone Marrow; Bone Marrow Cells; Bone Marrow Failure Disorders; Cell Proliferation; Chemokine CXCL12; Cyclams; Disease Models, Animal; Female; Hematopoiesis; Hematopoietic Stem Cells; Heterocyclic Compounds; Male; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, Transgenic; Receptors, CXCR4; Signal Transduction; Spinal Cord Injuries

2020
Effect of SDF-1/CXCR4 axis on the migration of transplanted bone mesenchymal stem cells mobilized by erythropoietin toward lesion sites following spinal cord injury.
    International journal of molecular medicine, 2015, Volume: 36, Issue:5

    Topics: Animals; Benzylamines; Cell Movement; Chemokine CXCL12; Cyclams; Erythropoietin; Female; Heterocyclic Compounds; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Rats; Rats, Sprague-Dawley; Receptors, CXCR4; Spinal Cord; Spinal Cord Injuries; Tumor Necrosis Factor-alpha

2015
AMD3100 inhibits the migration and differentiation of neural stem cells after spinal cord injury.
    Scientific reports, 2017, 03-06, Volume: 7, Issue:1

    Topics: Animals; Benzylamines; beta Catenin; Cell Differentiation; Cell Line; Cell Movement; Cell Proliferation; Cyclams; Disease Models, Animal; Down-Regulation; Heterocyclic Compounds; Locomotion; Male; Nestin; Neural Stem Cells; Neurons; Rats; Receptors, CXCR4; Signal Transduction; Spinal Cord Injuries

2017
Matrix metalloproteinase-9 and stromal cell-derived factor-1 act synergistically to support migration of blood-borne monocytes into the injured spinal cord.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2011, Nov-02, Volume: 31, Issue:44

    Topics: Animals; Benzylamines; Cell Movement; Cells, Cultured; Chemokine CXCL12; Cyclams; Disease Models, Animal; Enzyme Inhibitors; Female; Gene Expression Regulation; Green Fluorescent Proteins; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Macrophages; Matrix Metalloproteinase 9; Mice; Mice, Transgenic; Monocytes; RNA, Messenger; Spinal Cord Injuries; Sulfones; Time Factors

2011
2', 3'-Cyclic nucleotide 3'-phosphodiesterase cells derived from transplanted marrow stromal cells and host tissue contribute to perineurial compartment formation in injured rat spinal cord.
    Journal of neuroscience research, 2007, Volume: 85, Issue:1

    Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Animals; Benzylamines; Bone Marrow Cells; Bone Marrow Transplantation; Cell Count; Cell Differentiation; Cell Movement; Cells, Cultured; Chemokine CXCL12; Chemokines, CXC; Cyclams; Dose-Response Relationship, Drug; Female; Heterocyclic Compounds; Immunohistochemistry; Microscopy, Immunoelectron; Nerve Regeneration; Nerve Tissue Proteins; Rats; Receptors, CXCR4; Spinal Cord Injuries; Stromal Cells

2007